| 1. |
Peterlin, B. M., M. Sullivan, H. Westphal, and J. V. Maizel, Jr. 1978. Secondary structure map of psoralen-crosslinked adenovirus DNA studied by electron microscopy.Virology 86:391-397. |
| 2. |
Tilghman, S. M., D. C. Tiemeier, J. G. Seidman, B. M. Peterlin, M. Sullivan, J. V. Maizel, and P. Leder. 1978. Intervening sequence of DNA identified in the structural portion of a mouse beta-globin gene. Proc. Natl. Acad. Sci. USA 75:725-729.  |
| 3. |
Nossal, N. G., and B. M. Peterlin. 1979. DNA replication by bacteriophage T4 proteins. The T4 43, 32, 44/62, and 45 proteins are required for strand displacement synthesis at nicks in duplex DNA. J. Biol. Chem. 254:6032-6037. |
| 4. |
Obata, M., Y. Yamawaki-Kataoka, N. Takahashi, T. Kataoka, A. Shimizu, Y. Mano, J. G. Seidman, B. M. Peterlin, P. Leder, and T. Honjo. 1980. Immunoglobulin gamma 1 heavy chain gene: structural gene sequences cloned in a bacterial plasmid. Gene 9:87-97. |
| 5. |
Das, H. K., P. A. Biro, S. N. Cohen, H. A. Erlich, A. von Gabain, S. K. Lawrance, P. G. Lemaux, H. O. McDevitt, B. M. Peterlin, M. F. Schulz, A. K. Sood, and S. M. Weissman. 1983. Use of synthetic oligonucleotide probes complementary to genes for human HLA-DR alpha and beta as extension primers for the isolation of 5'-specific genomic clones. Proc. Natl. Acad. Sci. USA 80:1531-1535. |
| 6. |
Gonwa, T. A., B. M. Peterlin, and J. D. Stobo. 1983. Human-Ir genes: structure and function. Adv. Immunol. 34:71-96. |
| 7. |
Payne, R., F. M. Brodsky, B. M. Peterlin, and L. M. Young. 1983. "Bare lymphocytes" without immunodeficiency. Hum. Immunol. 6:219-227. |
| 8. |
Peterlin, B. M., T. A. Gonwa, and J. D. Stobo. 1984. Expression of HLA-DR by a human monocyte cell line is under transcriptional control. J. Mol. Cell. Immunol. 1:191-200. |
| 9. |
Hardy, K. J., B. M. Peterlin, R. E. Atchison, and J. D. Stobo. 1985. Regulation of expression of the human interferon gamma gene. Proc. Natl. Acad. Sci. USA 82:8173-177. |
| 10. |
Sullivan, K. E., J. D. Stobo, and B. M. Peterlin. 1985. Molecular analysis of the bare lymphocyte syndrome. J. Clin. Invest. 76:75-79. |
| 11. |
Calman, A. F., and B. M. Peterlin. 1986. Expression of T cell receptor genes in human B cells. J. Exp. Med. 164:1940-1957. |
| 12. |
Currey, K. M., B. M. Peterlin, and J. V. Maizel, Jr. 1986. Secondary structure of poliovirus RNA: correlation of computer- predicted with electron microscopically observed structure. Virology 148:33-46. |
| 13. |
Peterlin, B. M., P. A. Luciw, P. J. Barr, and M. D. Walker. 1986. Elevated levels of mRNA can account for the trans-activation of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 83:9734-9738. |
| 14. |
Wang, Y., and B. M. Peterlin. 1986. Methylation patterns of HLA-DR alpha genes in six mononuclear cell lines. Immunogenetics 24:298-303. |
| 15. |
Calman, A. F., and B. M. Peterlin. 1987. Mutant human B cell lines deficient in class II major histocompatibility complex transcription. J. Immunol. 139:2489-2495. |
| 16. |
Kao, S. Y., A. F. Calman, P. A. Luciw, and B. M. Peterlin. 1987. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature330:489-493. |
| 17. |
Peltz, G. A., B. Gallis, and B. M. Peterlin. 1987. Monoclonal antibody immunoprecipitation of cell membrane glycoproteins. Anal. Biochem. 167:239-244. |
| 18. |
Peterlin, B. M., K. J. Hardy, and A. S. Larsen. 1987. Chromatin structure of the HLA-DR alpha gene in different functional states of major histocompatibility complex class II gene expression. Mol. Cell. Biol. 7:1967-1972. |
| 19. |
Sullivan, K. E., A. F. Calman, M. Nakanishi, S. Y. Tsang, Y. Wang, and B. M. Peterlin. 1987. A model for the transcriptional regulation of MHC Class II genes.Immunology Today 8:289-293. |
| 20. |
Sullivan, K. E., and B. M. Peterlin. 1987. Transcriptional enhancers in the HLA-DQ subregion. Mol. Cell. Biol. 7:3315-3319. |
| 21. |
Tong-Starksen, S. E., P. A. Luciw, and B. M. Peterlin. 1987. Human immunodeficiency virus long terminal repeat responds to T-cell activation signals. Proc. Natl. Acad. Sci. USA 84:6845-6849. |
| 22. |
Wang, Y., A. S. Larsen, and B. M. Peterlin. 1987. A tissue-specific transcriptional enhancer is found in the body of the HLA-DR alpha gene. J. Exp. Med. 166:625-636. |
| 23. |
Calman, A. F., M. P. Busch, G. N. Vyas, T. M. McHugh, D. P. Stites, and B. M. Peterlin. 1988. Transcription and replication of human immunodeficiency virus-1 in B lymphocytes in vitro. AIDS 2:185-193. |
| 24. |
Calman, A. F., and B. M. Peterlin. 1988. Evidence for a trans-acting factor that regulates the transcription of class II major histocompatibility complex genes: genetic and functional analysis. Proc. Natl. Acad. Sci. USA 85:8830-8834. |
| 25. |
Fronek, Z., L. A. Timmerman, C. A. Alper, B. H. Hahn, K. Kalunian, B. M. Peterlin, and H. O. McDevitt. 1988. Major histocompatibility complex associations with systemic lupus erythematosus. Am. J. Med. 85:42-44. |
| 26. |
Peltz, G., K. Frederick, C. L. Anderson, and B. M. Peterlin. 1988. Characterization of the human monocyte high affinity Fc receptor (hu FcRI). Mol. Immunol. 25:243-250. |
| 27. |
Peterlin, B. M., and P. A. Luciw. 1988. Molecular biology of HIV. AIDS 2:S29-40. |
| 28. |
Peterlin, B. M., and P. A. Luciw. 1988. Replication of the human immunodeficiency virus: strategies for inhibition. Biotechnology 6:794-799. |
| 29. |
Seto, E., T. S. Yen, B. M. Peterlin, and J. H. Ou. 1988. Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein. Proc. Natl. Acad. Sci. USA 85:8286-8290. |
| 30. |
Tsang, S. Y., M. Nakanishi, and B. M. Peterlin. 1988. B-cell-specific and interferon-gamma-inducible regulation of the HLA-DR alpha gene. Proc. Natl. Acad. Sci. USA85:8598-8602. |
| 31. |
Bain, E. S., V. L. Lim, and B. M. Peterlin. 1989. Designing therapies for the treatment of AIDS. J. Biotech. 11:313-324. |
| 32. |
Selby, M. J., E. S. Bain, P. A. Luciw, and B. M. Peterlin. 1989. Structure, sequence, and position of the stem-loop in TAR determine transcriptional elongation by Tat through the HIV-1 long terminal repeat. Genes Dev. 3:547-558. |
| 33. |
Seto, E., D. X. Zhou, B. M. Peterlin, and T. S. Yen. 1989. Trans-activation by the hepatitis B virus X protein shows cell-type specificity. Virology 173:764-766. |
| 34. |
Tong-Starksen, S. E., P. A. Luciw, and B. M. Peterlin. 1989. Signaling through T lymphocyte surface proteins, TCR/CD3 and CD28, activates the HIV-1 long terminal repeat. J. Immunol. 142:702-7. |
| 35. |
Andersson, G., and B. M. Peterlin. 1990. NF-X2 that binds to the DRA X2-box is activator protein 1. Expression cloning of c-Jun. J. Immunol. 145:3456-462. |
| 36. |
Barry, P. A., E. Pratt-Lowe, B. M. Peterlin, and P. A. Luciw. 1990. Cytomegalovirus activates transcription directed by the long terminal repeat of human immunodeficiency virus type 1. J. Virol. 64:2932-2940. |
| 37. |
Fronek, Z., L. A. Timmerman, C. A. Alper, B. H. Hahn, K. Kalunian, B. M. Peterlin, and H. O. McDevitt. 1990. Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus. Arthritis Rheum. 33:1542-1553. |
| 38. |
Peterlin, B. M., G. Andersson, E. Lotscher, and S. Tsang. 1990. Transcriptional regulation of HLA class-II genes. Immunol. Res. 9:164-177. |
| 39. |
Selby, M. J., and B. M. Peterlin. 1990. Trans-activation by HIV-1 Tat via a heterologous RNA binding protein. Cell 62:769-776. |
| 40. |
Tong-Starksen, S. E., and B. M. Peterlin. 1990. Mechanisms of retrovirus transcriptional activation. Sem. Virol. 1:215-227. |
| 41. |
Tong-Starksen, S. E., T. M. Welsh, and B. M. Peterlin. 1990. Differences in transcriptional enhancers of HIV-1 and HIV-2. Response to T cell activation signals. J. Immunol. 145:4348-4354. |
| 42. |
Tsang, S. Y., M. Nakanishi, and B. M. Peterlin. 1990. Mutational analysis of the DRA promoter: cis-acting sequences and trans- acting factors. Mol. Cell. Biol. 10:711-719. |
| 43. |
Chin, D. J., M. J. Selby, and B. M. Peterlin. 1991. Human immunodeficiency virus type 1 Tat does not transactivate mature trans-acting responsive region RNA species in the nucleus or cytoplasm of primate cells. J. Virol. 65:1758-1764. |
| 44. |
Derse, D., M. Carvalho, R. Carroll, and B. M. Peterlin. 1991. A minimal lentivirus Tat. J. Virol. 65:7012-7015. |
| 45. |
Modesti, N., J. Garcia, C. Debouck, B.M. Peterlin, and R. Gaynor. 1991. Trans-dominant Tat mutants with alterations in the basic domain inhibit HIV-1 gene expression.New Biol. 3:759-768. |
| 46. |
Peterlin, B. M. 1991. Transcriptional regulation of HLA-DRA gene. Res. Immunol. 142:393-399. |
| 47. |
Alonso, A., D. Derse, and B. M. Peterlin. 1992. Human chromosome 12 is required for optimal interactions between Tat and TAR of human immunodeficiency virus type 1 in rodent cells. J. Virol. 66:4617-4621. |
| 48. |
Carroll, R., B. M. Peterlin, and D. Derse. 1992. Inhibition of human immunodeficiency virus type 1 Tat activity by coexpression of heterologous trans activators. J. Virol. 66:2000-2007. |
| 49. |
Voliva, C. F., A. Aronheim, M. D. Walker, and B. M. Peterlin. 1992. B-cell factor 1 is required for optimal expression of the DRA promoter in B cells. Mol. Cell. Biol. 12:2383-2390. |
| 50. |
Ghosh, S., M. J. Selby, and B. M. Peterlin. 1993. Synergism between Tat and VP16 in trans-activation of HIV-1 LTR. J. Mol. Biol. 234:610-619. |